60 minutes. Could it be true? Part two /
A look at the human test trials of SU5416, a new angiogenesis inhibitor, which shows promise as a cancer treatment. This is part two of a two-part segment. Ed Bradley reports.
| Other Authors: | , , |
|---|---|
| Format: | Video |
| Language: | English |
| Language Notes: | In English. |
| Published: |
New York, NY :
Columbia Broadcasting System,
1999.
|
| Subjects: | |
| Online Access: | Connect to this streaming video (Alexander Street Press) |
| Summary: | A look at the human test trials of SU5416, a new angiogenesis inhibitor, which shows promise as a cancer treatment. This is part two of a two-part segment. Ed Bradley reports. |
|---|---|
| Item Description: | Title from resource description page (viewed October 23, 2015). |
| Physical Description: | 1 online resource (13 minutes) |
| Playing Time: | 00:13:20 |